Hearings begin to finalize Purdue Pharma $7.4 billion bankruptcy settlement plan
(NEW YORK) -- Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company's owners, members of the Sackler families, from opioid litigation.The U.S. Supreme Court last year blocked an... Read More.










